Seagen Inc
Change company Symbol lookup
Select an option...
SGEN Seagen Inc
LGHL Lion Group Holding Ltd
EXEL Exelixis Inc
LBTYA Liberty Global PLC
TDOC Teladoc Health Inc
BRSH Bruush Oral Care Inc
RNA Avidity Biosciences Inc
ATAI ATAI Life Sciences NV
VTI Vanguard Total Stock Market Index Fund ETF Shares
AMPS Altus Power Inc
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

Seagen Inc. is a biotechnology company that develops and commercializes targeted therapies to treat cancer. The Company is engaged in commercializing ADCETRIS, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas; PADCEV, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers; TUKYSA, or tucatinib, for the treatment of certain metastatic human epidermal growth factor receptor 2 (HER2) -positive breast and colorectal cancers, and TIVDAK, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers. It is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients. Its programs including ADCETRIS, PADCEV and TIVDAK, are based on the Company’s antibody-drug conjugate (ADC) technology that utilizes the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells.

Closing Price
$203.08
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Average)
Volume:
1,305,003

10-day average volume:
1,267,794
1,305,003
  • Prev Close
    203.08
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    1.3M
  • Last (time)
    4:00p ET 03/30/23
  • Last (size)
    2
  • 52-Wk Range
    105.43 - 203.65
    LowHigh
  • (05/09/22 - 03/29/23)
    0.28%
  • 43.9%
  • Market Cap
    38.0B
  • Shares Outstanding
    187.1M
  • -3.30
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.5
  • 91.00
  • (% of float 03/15/23)
    0.98

Latest News

March 24, 2023
11:35 am ET
PR Newswire
March 23, 2023
2:58 pm ET
PR Newswire
10:55 am ET
Accesswire
10:08 am ET
Globe Newswire
March 20, 2023
7:56 am ET
MarketWatch
March 19, 2023
10:16 am ET
Globe Newswire
March 18, 2023
8:11 pm ET
Globe Newswire
March 16, 2023
5:25 pm ET
Accesswire
4:30 pm ET
PR Newswire
9:01 am ET
Accesswire
8:00 am ET
PR Newswire
March 15, 2023
4:49 pm ET
Globe Newswire
March 14, 2023
4:30 pm ET
BusinessWire
10:50 am ET
Accesswire
10:28 am ET
Globe Newswire
10:20 am ET
MarketWatch
8:43 am ET
Globe Newswire
4:30 am ET
PR Newswire
2:05 am ET
PR Newswire
March 13, 2023
6:14 pm ET
PR Newswire
5:20 pm ET
Newsfile
2:37 pm ET
MarketWatch
1:58 pm ET
Globe Newswire
12:20 pm ET
PR Newswire
12:05 pm ET
PR Newswire
9:31 am ET
PR Newswire
9:28 am ET
BusinessWire
6:55 am ET
MarketWatch
6:54 am ET
MarketWatch
6:54 am ET
MarketWatch
6:53 am ET
MarketWatch
6:53 am ET
MarketWatch
6:52 am ET
MarketWatch
6:45 am ET
BusinessWire
6:45 am ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.